PACE-CME

Invasive vs. conservative strategy does not reduce CV events in patients with CKD and ischemia

Invasive vs conservative strategy does not reduce CV events in patients with CKD and ischemia
RestartResume
3' education - Nov. 17, 2019 - Sripal Bangalore, MD, New york - AHA 2019, Philadelphia
  • Overview

    AHA 2019 The ISCHEMIA-CKD trial evaluated whether there is a benefit of adding coronary angiogrpahy and revascularization to OMT in patients with advanced CKD and at least moderate ischemia.

  • Educational information

    This video was recorded at the AHA in Philadelphia, USA, on november 18, 2019.

  • Faculty

    Sripal Bangalore, MD, MHA, FACC, FAHA, FSCAI is associate professor of medicine, director of research of the cardiac catheterization laboratory and director of the Cardiovascular Outcomes Group in the Cardiovascular Clinical Research Center at NYU Langone Health.

  • Disclosures

    This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of PACE-cme.

    Read our summary of the ISCHEMIA-CKD results

    The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.

Facebook Comments

Register

We’re glad to see you’re enjoying PACE-CME…
but how about a more personalized experience?

Register for free